Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120054) titled 'Optimized Therapeutic Effect of Silybin Capsules on Agomelatine-Induced Abnormal Liver Enzymes and Exploration of Its Underlying Mechanisms' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Condition:
Drug-induced liver injury
Intervention:
Silybin Capsules Group:Dministration of silybin capsules, 2 capsules each time, three times a day.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-20
Target Sample Size: Silybin Capsules Group:42;Polyene Phosphati...